✦ LIBER ✦

Chemoradiation for advanced head and neck carcinoma using concurrent weekly cisplatin chemotherapy

✍ Scribed by A. Winship; C. Thomas; M. O'Connell; F. Calman

Book ID: 119518246
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 128 KB
Volume: 82
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(07)80140-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent chemoradiation with daily low

Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma

✍ Frank J.P. Hoebers; Wilma Heemsbergen; Alfons J.M. Balm; Mathilde van Zanten; Ja 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Role of neck dissection following concur

Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma

✍ Véronique-Isabelle Forest; Phuc Félix Nguyen-Tan; Jean-Claude Tabet; Marie-Jo Ol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Background. Our primary objective was to determine the role of neck dissection following concomitant chemoradiation (CRT) for advanced stage III-IV head and neck squamous cell carcinoma (HNSCC). Methods. One hundred eighty-four patients with HNSCC treated with CRT were included. One hundred twenty-

AOSP16 COMPARISON OF ACUTE TOXICITY PROF

AOSP16 COMPARISON OF ACUTE TOXICITY PROFILE OF WEEKLY VERSUS 3-WEEKLY CISPLATIN IN CONCURRENT CHEMORADIATION FOR LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA

✍ Thommachan, K. Cessal; Kumar, R. Ravi; Haridas, G. Medini; Sudha, A. Sankar; Raf 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase II trial: concurrent radio-chemoth

Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

✍ A. Biete Solà; J. Marruecos Querol; F. A. Calvo Manuel; E. Verger Fransoy; À. Ro 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 469 KB

Comparative Study of Response, Toxicity,

Comparative Study of Response, Toxicity, and Quality of Life in Locally-Advanced Head-and-Neck Cancers With Concurrent Chemoradiation Therapy With 3 Weekly Cisplatin Versus Weekly Cisplatin Regimen

✍ Kesava Ramgopal, A.; Monica, I.; Pavankumar, L.; Syedakram, K.; Deepajoseph, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Low-dose weekly platinum-based chemoradi

Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer

✍ John M. Watkins; A. Jason Zauls; Amy H. Wahlquist; Keisuke Shirai; Elizabeth Gar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Objectives/Hypothesis: The optimal concurrent chemoradiotherapy regimen for definitive treatment of locoregionally advanced head and neck cancer remains to be determined. The present investigation reports toxicities, disease control, patterns of failure, and survival outcomes in a large mature cohor